Tom Thuren MD, PhD

Novartis Pharmaceuticals

Appearances

Requirement to Implement Anti-Inflammatory Treatment of Cardiometabolic Diseases
Date
January 26, 2021
Speaker
Tom Thuren, MD, PhD
Novartis Pharmaceuticals
[Joint Session] Career Roundtable
Date
January 26, 2021
Panelists
Donita C. Brady, PhD
University of Pennsylvania
Matthew G. Vander Heiden, MD, PhD
Massachusetts Institute of Technology
Tom Thuren, MD, PhD
Novartis Pharmaceuticals

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.